SABS GlobeNewswire 2 days ago SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
SABS GlobeNewswire 2 days ago SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
